CoreCap Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $819K | Sell |
17,696
-1,200
| -6% | -$55.5K | 0.03% | 390 |
|
|
2025
Q1 | $1.15M | Buy |
18,896
+1,395
| +8% | +$85.1K | 0.05% | 304 |
|
|
2024
Q4 | $990K | Buy |
17,501
+3,345
| +24% | +$189K | 0.05% | 334 |
|
|
2024
Q3 | $732K | Buy |
+14,156
| New | +$732K | 0.03% | 378 |
|
|
2024
Q2 | – | Sell |
-9,126
| Closed | -$495K | – | 1728 |
|
|
2024
Q1 | $495K | Buy |
9,126
+1,517
| +20% | +$82.3K | 0.03% | 401 |
|
|
2023
Q4 | $390K | Buy |
7,609
+1,944
| +34% | +$99.7K | 0.03% | 389 |
|
|
2023
Q3 | $329K | Buy |
5,665
+991
| +21% | +$57.5K | 0.02% | 398 |
|
|
2023
Q2 | $299K | Buy |
+4,674
| New | +$299K | 0.02% | 455 |
|
|
2022
Q4 | $1.73M | Buy |
24,090
+19,061
| +379% | +$1.37M | 0.12% | 151 |
|
|
2022
Q3 | $358K | Sell |
5,029
-261
| -5% | -$18.6K | 0.03% | 389 |
|
|
2022
Q2 | $407K | Sell |
5,290
-2,275
| -30% | -$175K | 0.03% | 358 |
|
|
2022
Q1 | $552K | Sell |
7,565
-223
| -3% | -$16.3K | 0.04% | 317 |
|
|
2021
Q4 | $486K | Buy |
+7,788
| New | +$486K | 0.03% | 371 |
|